P-077 - QT PROLONGATION RISK ASSESSMENT IN NON-ADC MONOCLONAL ANTIBODIES: A COMPREHENSIVE REVIEW OF FDA APPROVED IMMUNOLOGY, NEUROSCIENCE AND ONCOLOGY PRODUCTS BETWEEN 2015 AND 2020.

K. Huang, A. Mohammad, Z. Li, S. Bachhav; AbbVie Inc., North Chicago, IL, USA.

Presenting Author(s)

Kevin M. Huang, PhD

Senior Clinical Pharmacologist
AbbVie Inc.
NORTH CHICAGO, Illinois, United States